Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Rajneesh Jain"'
Publikováno v:
Indian Heart Journal, Vol 73, Iss , Pp S31- (2021)
Externí odkaz:
https://doaj.org/article/b90deef91ec1474e9c9d5115a44b7e31
Autor:
J.P.S. Sawhney, Shashi Ranjan Prasad, Manish Sharma, Kushal Madan, A. Mohanty, Rajiv Passey, Ashwani Mehta, B. Kandpal, Aman Makhija, Rajneesh Jain, R.R. Mantri, Bhola Shankar Vivek, S.C. Manchanda, I.C. Verma
Publikováno v:
Indian Heart Journal, Vol 71, Iss 2, Pp 118-122 (2019)
Aims: The prevalence of premature coronary artery disease (CAD) in India is two to three times more than other ethnic groups. Untreated heterozygous familial hypercholesterolemia (FH) is one of the important causes for premature CAD. As the age advan
Externí odkaz:
https://doaj.org/article/cd62a3cea114481baa6efd196f580d30
Autor:
Deepak Agrawal, S.C. Manchanda, J.P.S. Sawhney, Bhuwanesh Kandpal, Rajneesh Jain, Ashwani Mehta, Arun Mohanty, Rajiv Passey, Aman Makhija, Manish Kr. Sharma
Publikováno v:
Indian Heart Journal, Vol 70, Iss , Pp S8-S12 (2018)
Objective: Primary objective was to compare the effects of atorvastatin 40 mg vs 80 mg on LDL-C in Indian patients with atherosclerotic dyslipidemia. Secondary objectives were to compare the effects of atorvastatin 40 mg vs 80 mg on HDL-C and triglyc
Externí odkaz:
https://doaj.org/article/7e9e202e567a41439f18111a4364478a
Autor:
Kaushal Gandhi, R.R. Mantri, Rajneesh Jain, Rajiv Passey, J.P.S. Sawhney, Bhuwanesh Kandpal, Aman Makhija, B.S. Vivek
Publikováno v:
Indian Heart Journal, Vol 69, Iss S2, p S16 (2017)
Externí odkaz:
https://doaj.org/article/011ebb63eca64d52a53de8d418c4e335
Publikováno v:
Indian Journal of Community Health. 31:226-230
Background: Road traffic injuries are the eighth leading cause of death globally, and the leading cause of death for young people aged 15–29 years. Each year, almost 400,000 young people under 25 years old are killed in a road traffic crash - about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc5378eec6edca7db93342d5ae349b0a
https://doi.org/10.47203/ijch.2019.v31i02.012
https://doi.org/10.47203/ijch.2019.v31i02.012
Autor:
I.C. Verma, Rajneesh Jain, Bhuwanesh Kandpal, R.R. Mantri, Rajiv Passey, S.R. Prasad, Arun Mohanty, Aman Makhija, Ashwani Mehta, Kushal Madan, Bhola Shankar Vivek, J.P.S. Sawhney, Manish Sharma, Subhash C. Manchanda
Publikováno v:
Indian Heart Journal
Indian Heart Journal, Vol 71, Iss 2, Pp 118-122 (2019)
Indian Heart Journal, Vol 71, Iss 2, Pp 118-122 (2019)
Aims: The prevalence of premature coronary artery disease (CAD) in India is two to three times more than other ethnic groups. Untreated heterozygous familial hypercholesterolemia (FH) is one of the important causes for premature CAD. As the age advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01922af36799982cdf264ddd0b79e2b9
http://europepmc.org/articles/PMC6620422
http://europepmc.org/articles/PMC6620422
Autor:
J.P.S. Sawhney, Subhash C. Manchanda, Deepak Agrawal, Rajneesh Jain, Arun Mohanty, Bhuwanesh Kandpal, M.K. Sharma, Rajiv Passey, Ashwani Mehta, Aman Makhija
Publikováno v:
Indian Heart Journal
Indian Heart Journal, Vol 70, Iss, Pp S8-S12 (2018)
Indian Heart Journal, Vol 70, Iss, Pp S8-S12 (2018)
Objective: Primary objective was to compare the effects of atorvastatin 40 mg vs 80 mg on LDL-C in Indian patients with atherosclerotic dyslipidemia. Secondary objectives were to compare the effects of atorvastatin 40 mg vs 80 mg on HDL-C and triglyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3615db2034849779294924291fb6d71e
http://europepmc.org/articles/PMC6310693
http://europepmc.org/articles/PMC6310693
Publikováno v:
Indian J Clin Biochem
Small dense (sd) LDL is a significant independent risk factor for premature coronary artery disease (CAD). Unfortunately, its estimation is not popular, due to the limited availability of specialized equipment, high cost and time-consuming technique.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83c8e46c5999bba85ae7c35fef1f4a63
https://pubmed.ncbi.nlm.nih.gov/31391715
https://pubmed.ncbi.nlm.nih.gov/31391715
Autor:
Upendra, Kaul, Sripal, Bangalore, Ashok, Seth, Priyadarshini, Arambam, Rajpal K, Abhaichand, Rajpal K, Abhaychand, Tejas M, Patel, Darshan, Banker, Atul, Abhyankar, Ajit S, Mullasari, Sanjay, Shah, Rajneesh, Jain, Premchand R, Kumar, C G, Bahuleyan, Debdatta, Bhattacharya
Publikováno v:
New England Journal of Medicine. 373:1709-1719
The choice of drug-eluting stent in the treatment of patients with diabetes mellitus and coronary artery disease who are undergoing percutaneous coronary intervention (PCI) has been debated. Previous studies comparing paclitaxel-eluting stents with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d0f7b945d708d19ea0d57dcabc02ecc
https://doi.org/10.1056/nejmoa1510188
https://doi.org/10.1056/nejmoa1510188